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Abstract 
 
The burden of revision total hip replacement (THR) surgery is increasing. With an 
increasing life expectancy and younger age of primary surgery this trend is set to 
continue.  There is little data on the long-term outcome of revision THR. This 
retrospective study of 1,176 consecutive revision THRs with a minimum 10-year 
follow-up from a University Teaching Hospital was undertaken to review implant 
survival and patient reported outcomes. 
Mean follow-up was 11 years with implant survival at 10 years of 82% (CI: 80 – 85). 
Implant survival varied between 58% (unexplained pain) to 84% (aseptic loosening) 
depending on the indication for revision surgery. Positive predictors of survival were 
age greater than 70 at the time of surgery (p=0.011), revision for aseptic loosening 
(p<0.01) and revision of both components or just the acetabular component (p<0.01). 
At the last review, mean Oxford Hip Score (OHS) was 34 (SD: 11.3) and 92% of the 
living patients with unrevised hips were satisfied with the outcome of revision 
surgery.  
This long term study has demonstrated that positive predictors of survival and 
outcome of revision THR surgery are age greater than 70 years, revision for aseptic 
loosening and component revision. This should aid surgeons in their counselling of 
patients prior to surgery. 
 
 
Keywords: Revision Total Hip Replacement, Survival, Outcome predictors, 10-year 
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 1. Introduction 
The introduction of a well functioning primary Total Hip Replacement (THR) by 
Charnley in 1962 has led to THR today providing excellent clinical outcomes and 
survival for those with a variety of hip pathologies [1,2]. Furthermore, multiple series 
are available which allow clinicians to give predictions of outcome with different 
implants [3-5]. However, the constant growth in the number of THRs performed 
every year, the increasing number of primary surgeries being performed at a younger 
age and increased life expectancy have contributed to a significant increase in the 
revision burden [6, 7]. 
 
Survivorship of revision hip surgery has been well documented but is usually in the 
form of small single surgeon series. We are aware of only two published series with 
greater than 1000 cases that quote 10-year survival, (72% to 82%) [8,9].  
 
Patient Reported Outcome Measures (PROMs) are increasingly being used to 
document implant success, as well as being used as a tool to define treatment options 
[11]. Evidence to support predicting functional outcome post revision is limited and, 
when available, the data usually reflect small numbers and short follow-up [12,13].  
  
The aim of this retrospective observational study was to assess patients with a 
minimum of 10 year follow-up who had a revision THR performed at a single tertiary 
referral unit (University Teaching Hospital) to assess what factors, if any, were the 
predictors of survival, function and patient satisfaction. 
 
 2. Materials and Methods  
Theatre logbooks between 1996 and 2002 at the Nuffield Orthopaedic Centre, Oxford, 
UK were retrieved. All revision THRs were identified and the operative notes 
examined to obtain relevant data in a standardised fashion. Cases were excluded if the 
primary procedure was not a THR or if the revision procedure was not the first 
revision surgery on that joint, (thus cases of conversion of hemiarthroplasty and hip 
resurfacing, Girdlestone procedures and re-revision were excluded).  
 
The revisions were further defined according to the components revised. Revisions 
involving exchange of the cup and stem were classified as revisions of “both 
components.” Acetabular cup revision was classified as “cup only”, stem alone 
revision was classified as “stem only”, head and/or liner exchange as “isolated 
head/liner” revision and those requiring a two-stage revision of both components as 
“two-stage revision”.  
 
Following the identification of appropriate patients, the components revised and 
indications for revision surgery were obtained from medical notes and clinic letters. 
Component loosening, with or without instability, was defined as “aseptic loosening” 
with revision for dislocation or subluxation classified as “instability”. Revision for 
fracture in the absence of infection was classified as “peri-prosthetic fracture” and 
other diagnoses for revision, for example prosthesis fracture, heterotopic ossification 
and leg length discrepancy, were classified as “other”.  Pain in the absence of any of 
the previously mentioned causes was defined as “unexplained pain”.  In the cases of 
revision for suspected infection, the clinical suspicion was confirmed by histological 
and microbiological investigation with the infecting organism identified where 
possible.  Isolation of the same organism(s) in more than three separate samples 
and/or the presence of more than five white blood cells per high power microscopy 
field in any of the histology samples were considered diagnostic of infection [14,15]. 
If the patient presented with a sinus tract, the case was considered to be infected even 
in the absence of positive microbiology or histology [16]. These cases formed the 
“infected group”. 
 
Local ethics committee confirmed that no formal approval was necessary for this 
study. All patients were contacted to assess their functional outcome with the Oxford 
Hip Score (OHS) [17,18] and a study specific questionnaire. If one or two OHS 
questions were unanswered, a mean value representing all other responses was 
calculated and used for missing values [17]. OHS questionnaires with three or more 
missing responses were deemed invalid [17]. Patient reported satisfaction was defined 
using a nominal scale (1: Very displeased, 2: Not very pleased, 3: Fairly pleased, 4: 
Very pleased). Patients who responded as either “very displeased” or “not very 
pleased” were classified as “unsatisfied”, with the remaining responses deemed to be 
“satisfied”.  
 
All patient responses were compared with all hospital documentation to check for 
discrepancies and, in the case of deceased patients, for implant failure. Non-
responders were sent follow-up letters and, in the case of those who did not reply, 
their General Practitioner was contacted. All patients who were either lost to follow-
up or who had died were utilised in the analysis and were censored at either the time 
of death or when their last documented review.  
2.1 Statistical Analysis 
Statistical analysis of the data was carried out using SPSS for Windows v 18.0 (SPSS 
Inc., Chicago, Illinois). Covariates tested were: gender, patient age at revision, the 
revision undertaken, the indication for revision and the method of fixation. Patients 
were divided into two age groups: those under 70 years at the time of surgery formed 
the “young” group, with the remaining patients defined as being in the “old” group. 
 
Survival data were obtained by Kaplan-Meier analysis [19].  Survival was calculated 
with a failure defined as any operation in which a component was exchanged or 
removed. Significant differences in survivorship were established using Log-rank 
tests and significant variables were then analysed using a multivariate Cox model, 
taking into account interaction terms, in order to estimate the true magnitude of 
influence of each covariate on implant survivorship.  
 
The Mann Witney-U test assessed the influence of each covariate upon patient 
reported outcome. A significance level of p<0.05 was used throughout. 
 
3. Results 
A total of 1,336 hip revision procedures were identified of which 1,176 cases were the 
first revision of a THR. 1,054 (90%) were performed by five orthopaedic surgeons 
with a specialist interest in arthroplasty surgery. Of these 1,109 patients, 67 had 
bilateral revisions. The mean age at surgery was 68 years, (range: 23 to 97 years) and 
mean follow up was 11 years (range 2 to 14 years). 632 patients were female and 26 
patients were lost to follow up.  Functional questionnaires were returned in 79% of 
living patients.  
 Both components were revised in 576 hips (49%); the acetabular cup alone was 
revised in 306 cases (26%); the stem only in 188 cases (16%). A two-stage revision 
was performed in 94 cases (8%) and there was an isolated head/liner exchange in 12 
cases (1%). In total, 14 different types of acetabular cup and 12 different stems were 
implanted. All revised stems were cemented with 278 of the revised acetabular cups 
being uncemented,  
 
Revision was performed for aseptic loosening in 843 cases (72%), infection in 111 
cases (9%), periprosthetic fracture in 92 cases (8%), instability in 64 cases (5%), 
“unexplained pain” in 19 cases (2%) and for “other” reasons in 47 cases (4%). 
 
Of the 111 cases revised for infection, 66 cases had a two-stage revision. 16 patients, 
(16 cases), were not deemed to be fit enough for a two-stage procedure and so had a 
single-stage revision. Additionally, a further 29 hips who had a single-stage revision 
were retrospectively identified through microbiological or histological findings as 
having an underlying infection and so were also included in the “infected” group. 
 
  3.1 Survival 
The 10-year survivorship of all-cause revision was 82% (95% CI: 80 to 85) (figure 1). 
At mean follow-up of 11 years, 440 hips were deceased of which 56 had been re-
revised prior to death. Of the 772 living cases, 148 were re-revised prior to follow-up 
and 27 hips were lost to follow-up (2.3%).  
 
Gender had no influence on survival with 10-year survivorship 83% (95% CI:80-87)  
in men and 82% (95% CI: 78-85) in women (log-rank, p=0.80) (table 1). Implant 
survivorship at 10 years in the Old group, (patients older than 70 years at revision 
surgery), was 89% (95% CI: 86-92) and significantly better (log-rank, p=0.01) than 
that of the Young group (79%, 95% CI: 75-82). Furthermore the survivorship in those 
under 60 years was 74% at 10 years and 85% in those over 60 (log-rank p=0.01). 
 
10-year survivorship when both components were revised (84%, 95% CI: 80-87) and 
when the cup only was revised (86%, 95% CI: 82 - 90) was significantly better (log-
rank p=0.01) than when the stem only was revised (77%, 95% CI: 70-84).  Isolated 
head/liner exchange and two-stage revision had survivorship at 10 years of 60% (95% 
CI: 32-87) and 76% (95% CI: 67-86) respectively (figure 2). There was no significant 
difference (log-rank = 0.37) when comparing cemented hip survival, (where both 
components were cemented, 84%), versus hybrid survival at 10 years which was 81% 
(and where the acetabular component was uncemented). 
 
Revision for aseptic loosening had a significantly (log-rank, p<0.01) better 10-year 
survival (84%, 95% CI: 82-87) than revision for infection (78% 95% CI: 69-86), 
instability (78% 95% CI: 66-90), periprosthetic fracture (73% 95% CI: 62-85) and 
unexplained pain (58% 95% CI: 32-83) (figure 3).  
 
Sub-group analysis revealed that revision for aseptic loosening had the best 10-year 
survival if revision was “both components or cup only” compared to “stem only” 
(85% v 77%, log-rank p=0.03). Similarly, those cases revised for instability had 
significantly better 10-year survival (log-rank, p<0.01) if the procedure was an 
exchange of “both components, cup only or stem only” (84%) compared with those 
who underwent a “head/liner change” (47%). However, the numbers in the latter 
group were low, (10 cases), compared with the 52 cases in the other group.  
Subgroup analysis of the “infected” group did not show any significant difference 
(log rank p=0.57) between the implant survival for one-stage revision (81% at 10 
years) when compared with two-stage revision (76% at 10 years).  
 
Multivariate Cox regression analysis revealed the age category, type of procedure and 
revision indication significantly influenced (p=0.011, p=0.014, p=0.041) revision 
implant survival although gender did not (p=0.75). 
 
  3.2 Oxford Hip Score 
Mean OHS at follow-up was 34 (SD: 11.3, range: 3 - 48) (figure 4). Gender, age 
category, method of fixation or indication had no significant influence on OHS at 10 
years post revision THR.  However, there was a trend for a higher OHS in younger 
patients, male patients and those revised as a “single-stage” procedure. 
 
In patients where there was a revision of “both” components and “cup only” revisions 
there were significantly, (p=0.003), higher OHSs compared to patients’ whose “stem 
only” was revised (mean: 34, SD: 10.9 Vs mean: 30, SD: 11.6 respectively). Although 
not significant (p=0.55), revisions where there was an isolated liner/head change 
(mean: 31, SD: 9.2) or where a two-stage procedure occurred (mean 32, SD: 12.9) 
had poorer OHS than other groups (figure 5). 
 
The indication for revision did not significantly influence outcome. The mean OHS 
for patients revised for “aseptic loosening” was 34 (SD: 11.2), unexplained pain was 
34 (SD: 6.2) and “other” was 35 (SD: 11.2) which was higher than those revised for 
infection, instability and periprosthetic fracture (means: 32, 33, 31; SD: 12.3, 12.2, 
11.7 respectively) 
 
The mean OHS for one stage revision was 32 (SD: 8.8, Range: 15 - 46), which 
compared to a mean OHS of 32 (SD: 11.7 Range: 5 - 48) for those undergoing a two-
stage revision for infection. This was not significant (Mann-Whitney U, p=0.71). 
 
If end-point for survival included OHS of <20 and revision, survival dropped to 77%.  
 
  3.3 Patient Satisfaction 
92% of patients were satisfied with their revision operation (Table 2). Gender, age 
category, procedure, fixation method, and indication had no significant influence on 
patient reported satisfaction. There was however a trend towards higher satisfaction 
for “aseptic loosening” (92%) compared to revision for infection (85%) and 
periprosthetic fracture (84%). It was noted that those revised for instability and 
unexplained pain reported 100% satisfaction at follow-up, (although this was not 
statistically significant). 
 
Additionally, two-stage revisions and procedures where there was an isolated 
head/liner exchange had low satisfactions of 82% and 80% respectively. This 
compared with higher satisfaction rates (93%) post revision of “both components”, 
“cup only” revision and one stage revision. 
 Patient reported satisfaction was strongly correlated with functional outcome with a 
correlation coefficient of 0.534 (p<0.001). 
 
4. Discussion 
This long-term study of outcomes and survival following revision THR has shown 
that generally the outcome of revision THR is good and four out of five patients will 
not need a re-revision at least for 10 years. It provides further evidence that patient 
age and revision for aseptic loosening are positive predictors of survival in primary 
revision hip surgery. This information is useful for patient counselling, especially the 
young patients who are about to undergo primary THR.  
 
This is the first long term study to demonstrate a correlation between a PROMs and 
method of revision, as well as, overall patient satisfaction. Those revised for 
unexplained pain tend to have a worse outcome in terms of implant survival although 
in those not needing re-revision, the rate of satisfaction is highest. 
 
A survivorship of 82% at 10-years is comparable to other reported literature outcomes 
[9] but remains poorer when compared to primary THR [1,2]. This study has longer 
follow-up, (mean 11 years), when compared with similar large sample studies [9,10]. 
 
Primary revision for “aseptic loosening” had a significantly (log-rank, p=<0.01) better 
survival rate of 84% compared with other indications for revision, which provides 
further evidence that this indication is a positive predictor of survival. Other 
significant influences on survival were age greater than 70 at the time of revision and 
the type of procedure performed.  
 
Analysis of the effect of patient age also showed that survival in those under 60 was 
74% in comparison to those over 60, whose survival was 85%. An age greater than 70 
has been previously shown to predict outcome [10], but with the patient age of 
primary THR reducing it can be expected that the age at which revision occurs will 
also reduce. A 10-year survival of 74% is comparable with other 10-year outcomes 
[8] but given the difference between the two groups it would suggest that revision in 
those under 60 should if possible be delayed, particularly when the survival in those 
under 70 years rises to 79%.    
 
Our study has shown at 10 years that the only positive predictor of functional 
outcome was a revision of both components. Previously, short-term follow-up has 
demonstrated that age, gender and operative indication have a predictive outcome on 
revision THR [12,13]. Our longer-term study with greater numbers did not show a 
significant link, although there was a trend for a better outcome in young, male 
patients who had a single stage procedure. Although different functional outcome 
measures were used in this study when compared to others, the OHS has previously 
been shown to be a valid patient based outcome measure for revision THR [20].  
 
Of note is that, although not significant, patients revised for unexplained pain had 
better satisfaction post-operatively than any other group. By contrast, the same group 
had the lowest survival (58% 95% CI: 32-83), which was statistically significant.  
This discrepancy between satisfaction rates and implant survival is difficult to 
explain. Poor survival suggests that hips should not be revised without sufficient 
cause, a sentiment previously stated by other orthopaedic surgeons [21]. However, 
those who did not need re-revision, were very pleased with the outcome and the mean 
OHS was not dissimilar to other groups.  
 
PROMs are increasingly being used to define the success of an operative outcome. 
However, the correlation between PROMs and patient satisfaction is variable and, 
although a relatively simple measure, purely reported patient satisfaction could be 
argued as being a true definition of operative success. It is interesting to note that the 
OHS correlated strongly with patient satisfaction and was not significantly different 
between groups of patients revised for specific indications. Yet, there remains a 
contradiction as in those patient groups that were the most satisfied, the overall 
survival was poorer than the overall mean and particularly in those revised for 
unexplained pain. Further research into this contradiction is clearly required. 
 
Post revision surgery the mean OHS was 34 in our study demonstrating the success of 
primary revision hip surgery in comparison to the initial pathology. However, if one 
assumes that an OHS less than 20 represents a poor functional outcome, (as it is 
comparable to the initial pre-primary THR OHS [22]), the survival of revision THR 
falls to 77% at 10 years. These data are crucial for surgeons when counselling patients 
who are being listed for a primary revision.  A patient can expect approximately a 
four out of five chance that the revision surgery will not only last for 10 years but will 
also be better than their original pre-primary status.  
 
Patient satisfaction has previously been reported to reflect outcome [5,23]. Our long-
term study on a large cohort of patients confirms that there is a significant (p<0.001) 
correlation between functional outcome and satisfaction. However, the correlation 
that existed (corr. coeff. = 0.534) was only fair. This shows the importance of using 
multiple outcome measures to define operation success rather than relying on a single 
outcome score and certainly is a weakness of the study.   
 
We recognise the limitations of a retrospective study such as this. It would certainly 
be beneficial to be able to provide pre-operative assessments to compare our 
outcomes too, as well as more initial demographic data. Additionally, despite our 
rigorous attempts to cross check patients, (both alive and deceased), it is possible that 
deceased patients could have had a further revision at another centre. However, a 
worst case survival scenario of 79% is still comparable to previously reported 
outcomes. Furthermore, our large cohort it is a very heterogeneous group. However, 
rather than a weakness we believe it represents a strength as it provides a real picture 
of primary revision THR in day-to-day clinical practice. 
 
5. Conclusion 
In conclusion, this study demonstrates that primary revision hip surgery in those 
patients over 70 years, for aseptic loosening and with revision of both components 
provides a positive predictor of survival at 10 years. Additionally, this study shows 
that in this cohort of patients improved functional outcome measures correlated with 
younger patients who had a “single-stage” revision and that overall patient 
satisfaction is high for primary hip revision surgery. Further research is though 
necessary into predictors of PROMs. 
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     Procedure Both components 576 84 80-87 
 
Cup only  306 86 82-90 
 
Stem only  188 77 70-84 
 
Two-stage revision 94 76 67-86 
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Infection 111 78 69-86 
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Unexplained pain 19 58 32-83 
 Other 47     
 
Table 2: A table demonstrating the proportion of patients that were satisfied with their 
revision outcome (numbers in brackets show actual number of patients) 
 
Unsatisfied Satisfied 
8.2% (41) 91.8% (459) 
Very pleased Not very pleased Fairly pleased Very pleased 
4.4% (22) 3.8% (19) 20.8% (104) 71.0% (355) 
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